# Park National Corp: overview

PRK · NYSE · CIK 805676 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prk.md) · [Financials](/companies/prk/financials.md) · [Filings](/companies/prk/filings.md) · [Insiders](/companies/prk/insiders.md)

Latest reported revenue: [$211.9m](/filings/0000805676-26-000061.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:Revenues, accession 0000805676-26-000061).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [170](/filings/0000805676-25-000086.md) | [165 d](/filings/0000805676-26-000017.md) | [158](/filings/0000805676-26-000039.md) | [169](/filings/0000805676-26-000061.md) | [170](/filings/0000805676-25-000086.md) | [168 d](/filings/0000805676-26-000017.md) | [189](/filings/0000805676-26-000039.md) | [212](/filings/0000805676-26-000061.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [22.4%](/filings/0000805676-25-000086.md) | [23.5% d](/filings/0000805676-26-000017.md) | [26.7%](/filings/0000805676-26-000039.md) | [28.5%](/filings/0000805676-26-000061.md) | [27.8%](/filings/0000805676-25-000086.md) | [25.3% d](/filings/0000805676-26-000017.md) | [22.1%](/filings/0000805676-26-000039.md) | [27.7%](/filings/0000805676-26-000061.md) |
| Diluted EPS | $ per share | [2.35](/filings/0000805676-25-000086.md) | not reported | [2.60](/filings/0000805676-26-000039.md) | [2.97](/filings/0000805676-26-000061.md) | [2.92](/filings/0000805676-25-000086.md) | not reported | [2.39](/filings/0000805676-26-000039.md) | [3.23](/filings/0000805676-26-000061.md) |
| Free cash flow | $m | [41.7 d](/filings/0000805676-25-000086.md) | [47.1 d](/filings/0000805676-26-000017.md) | [36.6](/filings/0000805676-26-000039.md) | [48.2 d](/filings/0000805676-26-000061.md) | [51.4 d](/filings/0000805676-25-000086.md) | [55.7 d](/filings/0000805676-26-000017.md) | [26.6](/filings/0000805676-26-000039.md) | [50.5 d](/filings/0000805676-26-000061.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [514](/filings/0000805676-25-000014.md) | [564](/filings/0000805676-26-000017.md) | [646](/filings/0000805676-26-000017.md) | [664](/filings/0000805676-26-000017.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | [28.9%](/filings/0000805676-25-000014.md) | [22.5%](/filings/0000805676-26-000017.md) | [23.5%](/filings/0000805676-26-000017.md) | [27.1%](/filings/0000805676-26-000017.md) |
| Diluted EPS | $ per share | [9.37](/filings/0000805676-24-000037.md) | [9.06](/filings/0000805676-25-000014.md) | [7.80](/filings/0000805676-26-000017.md) | [9.32](/filings/0000805676-26-000017.md) | [11.11](/filings/0000805676-26-000017.md) |
| Free cash flow | $m | [143](/filings/0000805676-24-000037.md) | [129](/filings/0000805676-25-000014.md) | [144](/filings/0000805676-26-000017.md) | [170](/filings/0000805676-26-000017.md) | [192](/filings/0000805676-26-000017.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/prk/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $473.8m | 2,589,288 |  | Added +166,274 |
| [PARK NATIONAL CORP /OH/](/funds/805676.md) | 2026-06-30 | $206.4m | 1,127,922 |  | Reduced −28,042 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $183.8m | 1,004,211 |  | Added +34,883 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $159.9m | 873,685 |  | Added +126,527 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $134.0m | 732,031 |  | Reduced −2,355 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $95.9m | 524,189 |  | Added +6,757 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $78.2m | 427,073 |  | Added +45,421 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $34.6m | 189,059 |  | Added +8,533 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $32.5m | 177,490 |  | Added +21,763 |
| [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $23.7m | 129,254 |  | Added +13,245 |

## Recent filings

[All 1,140 filings](/companies/prk/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 16:17 ET | [8-K](/filings/0000805676-26-000069.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000805676-26-000069 |
| 2026-08-07 | 16:16 ET | [8-K](/filings/0000805676-26-000062.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805676-26-000062 |
| 2026-08-07 | 16:15 ET | [10-Q](/filings/0000805676-26-000061.md) | Quarterly report, period 2026-06-30 | 0000805676-26-000061 |
| 2026-07-27 | 16:15 ET | [8-K](/filings/0000805676-26-000057.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000805676-26-000057 |
| 2026-05-22 | 08:33 ET | [8-K](/filings/0000805676-26-000051.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805676-26-000051 |
| 2026-05-11 | 16:16 ET | [10-Q](/filings/0000805676-26-000039.md) | Quarterly report, period 2026-03-31 | 0000805676-26-000039 |
| 2026-04-28 | 16:15 ET | [8-K](/filings/0000805676-26-000036.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000805676-26-000036 |
| 2026-04-27 | 08:30 ET | [8-K](/filings/0000805676-26-000033.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000805676-26-000033 |
| 2026-04-24 | 16:15 ET | [8-K](/filings/0000805676-26-000031.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000805676-26-000031 |
| 2026-03-09 | 08:24 ET | [DEF 14A](/filings/0000805676-26-000021.md) | Proxy statement, period 2026-04-27 | 0000805676-26-000021 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000805676-26-000017.md), filed Feb 23, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/56a3edce-33f0-4420-bbae-ba61c878e3d1)

## About the filer

- CIK: 805676
- Tickers: PRK
- Exchange: NYSE
- SIC code: 6021 National Commercial Banks
- State of incorporation: OH
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 09:46 ET. No prices; not investment advice.